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it is unlikely to be able to substantially reduce injectable medicines’ prescription 
without addressing the issue.
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Objectives: Medication errors that occur in the acute care setting can lead to 
increased utilization of health care resources, especially when they cause tem-
porary or permanent patient harm. A pragmatic literature review was conducted 
to assess the clinical and economic impact of medication errors in Canadian 
hospitals. MethOds: A search of the MEDLINE database was conducted using the 
subject terms “medication error”, “preventable adverse drug event” and “Canada”. 
Studies were included if they described the frequency or cost of medication errors 
or preventable adverse drug events (pADEs) (defined as medication errors that 
cause patient harm), were conducted in a Canadian acute care setting, and were 
published in the last decade. Additional studies were selected from reference lists 
of identified studies. Studies were assessed for study design, setting, type of medi-
cations studied, and outcomes measured (event frequency, costs). Results: Eight 
studies were identified between 2004 and 2014. One study estimated the frequency 
of all pADEs at the national level using analysis of retrospective chart reviews 
(0.08% per admission). The remaining seven studies were conducted at individual 
institutions across Canada. Of these, three studies used chart review analysis to 
quantify the frequency of errors among all drug types (between 1.1% and 3.8% 
of all admissions), while four studies used chart review and direct observation 
to focus on quantifying the frequency of specific types of errors (dosing, label-
ling) for specific drug types (opioids, other IV medications). No studies assessed 
the cost of errors. cOnclusiOns: Results of studies at both the national and 
regional level demonstrate that medication errors pose a significant clinical bur-
den to patient care in Canadian acute care settings. Further research is needed to 
quantify the economic burden of these events to the health care system, in order 
to assist policy-makers and health administrators in prioritizing policies that 
support prevention efforts.
PHP181
u.s. Payer exPeCTaTions for reimBursemenT of Biosimilars
Malik AN, Keeping K, Fletcher-Louis M
Decision Resources Group, London, UK
Objectives: U.S. healthcare spending on high-cost biologics has escalated over 
the past decade. The Biologics Price Competition and Innovation Act allows for 
biosimilar products in the U.S., which will be lower-cost alternatives to reference 
biologics. This study explored payer attitudes to the reimbursement and adoption 
of biosimilars in the U.S. MethOds: Medical or pharmacy directors at managed 
care organizations (MCOs) were surveyed during April 2015 regarding their expec-
tations for biosimilar reimbursement. Results: Eligible respondents (n= 59) indi-
cate that MCOs expect biosimilars to offer a significant discount to the reference 
brand to secure reimbursement. A mean discount of 22–23% is considered adequate, 
while 29–30% is deemed necessary for preferential reimbursement to the reference 
brand. Rapid formulary inclusion of biosimilars is expected; 72% of respondents 
indicate formulary inclusion within 12 months of launch for the first entrant in 
a class. Widespread reimbursement of biosimilars in extrapolated indications is, 
however, uncertain, with only 29% of respondents reporting that their MCO would 
unconditionally reimburse a biosimilar under such circumstances. Payers expect 
to employ various strategies to promote biosimilar uptake, from favorable tiering to 
step edits; the most conducive strategies are expected for products with deep dis-
counts. Payers will also run educational campaigns for physicians. However, ≥ 63% of 
respondents expect their approach to be influenced by thought-leading physicians 
and medical associations. A large proportion of respondents expect “grandfather-
ing” (continuation of the reference brand in responsive/stable patients) to be per-
mitted, particularly when the biosimilar discount is modest. cOnclusiOns: U.S. 
payers will preferentially promote biosimilars over reference brands using various 
demand- and supply-side measures, provided that biosimilars meet their discount 
expectations and have clinical stakeholder buy-in. Payers clearly seek to realize the 
cost savings biosimilars offer; however, tendency to seek clinical stakeholder buy-
in, coupled with “grandfathering”, indicates some need for more robust evidence 
of cost-effectiveness.
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Objectives: To understand the trends and drivers of local decision-making by 
Clinical Commissioning Groups (CCGs), and how they may vary across localities, 
therapy areas, and by respective performance against key performance indicators 
(KPIs). MethOds: The MIMS website was searched to derive an exhaustive list 
of new pharmacotherapies between April 2013 and April 2015. This list was cross 
checked against all assessments conducted by the National Institute for Health 
and Care Excellence (NICE). The products that had been reviewed by NICE were 
subsequently excluded, given CCGs must implement any recommendation by NICE 
and hence does not demonstrate local decision making. Secondly, a representa-
tive sample of CCGs were selected across the regional locations of North, South, 
Midlands and East of England, and London (as defined by the NHS England regional 
team structure). A sample of 20 CCGs were shortlisted and their respective formu-
lary lists analysed to capture their commissioning decisions on the non-Nationally 
assessed pharmacotherapies. Finally, CCG commissioning decisions on the sample 
products was correlated against any local key performance indicators or priorities, 
the CCG Outcome Indicators, and their respective performance against them, to 
Objectives: Medication analysis (MA) and medication management (MM) are 
increasingly implemented in community pharmacies. However, little is known about 
the main intention of pharmacy owners to provide medication analysis in Germany. 
Thus, the objective of this study was to explore awareness of MA and MM and to 
predict the intention to provide MA. MethOds: Approximately 2,700 pharmacies 
listed in the database of the Bavarian Chamber of Pharmacists were invited via email 
to complete the web-based online survey (February/March 2015). The survey instru-
ment was designed to assess the constructs of attitude, perceived behavioral control, 
subjective norm and intention to provide MA, based on the theory of planned behav-
ior. Data were analyzed by using descriptive statistics. Linear regression models 
were used to predict the intention to provide MA. Results: A total of 295 phar-
macy owners completed the survey. More than half of the respondents (66.8%) rated 
themselves as familiar or very familiar with the term MA, with slightly more than 
half of the respondents (55.2%) offering MA. Overall, 70.9% of the respondents rated 
themselves as familiar or very familiar with the concept of MM, whereas only 25.1% 
stated to provide MM in their pharmacy. Perceived barriers included a lack of time 
and staff. The linear regression analysis revealed significant predictors of pharmacy 
owners’ intention to provide MA. These comprised the constructs of attitude, subjec-
tive norm and perceived behavioral control (p< 0.05), whereas gender and number of 
employees did not have a significant effect. cOnclusiOns: Findings suggest that 
community pharmacists are aware of the concepts of MA and MM. Attitude, subjec-
tive norm and perceived behavioral control were significant predictors of intention 
to provide MA. Strategies to improve the intention of community pharmacists to 
provide MA should focus on these predictors and the perceived barriers that impede 
the provision of MA in Germany.
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Objectives: Even though physician rating websites (PRWs) have become more 
important in recent years, little is known about the relationship between quality 
of care of physicians and patients’ online ratings. It still remains unclear whether 
these ratings are a reliable source for patients for choosing a physician. The aim 
of the study was to measure the association between structural and quality of 
care measures and online ratings in a German Integrated Healthcare Network 
(QuE). MethOds: Data from 65 QuE practices were collected and comprised 21 
indicators related to process quality (N= 10), structural information (N= 6), inter-
mediate outcomes (N= 2), costs (N= 2) and patient satisfaction (N= 1) for the year 
2012. We analyzed patients’ online ratings from two German PRWs (N= 1,179 and 
N= 991) over a three-year period (2011 to 2013). We applied the Spearman rank 
coefficient of correlation to measure the association between practice-related 
information and patient ratings. Results: For both PRWs, patient satisfaction 
results from offline surveys and the patients per doctor ratio in a practice were 
shown to be significantly associated with online ratings. Significant associations 
could be shown between online ratings and cost-related measures for medica-
tion, preventative examinations, and one diabetes type 2-related intermediate 
outcome measure on one PRW. Results from the second PRW showed significant 
associations with the number of patients per practice and the age of the physi-
cians, one cost-related measure for medication and four process-related quality 
measures. cOnclusiOns: Significant associations observed in this study varied 
across different PRWs. When choosing a doctor, patients interested in the satisfac-
tion of other patients with a physician might rely on online ratings. Even though 
our results indicate associations with some diabetes and asthma measures, but 
not with coronary heart disease measures, there is still insufficient evidence to 
draw strong conclusions. Findings may be weakened due to the limited number 
of practices considered.
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Objectives: Overuse of injections is a common problem in many low-income 
and middle income countries. While cultural factors and attitudes of both physi-
cians and patients are important factors, physicians’ financial intensives may 
play an important role in overprescribing of injections. This study was designed 
to assess the effects of providing injection services in physicians’ ambulatory 
offices on prescribing injectable medicines. MethOds: This cross-sectional 
study was conducted in Tehran in 2012 -2013and included a random sample of 
general physicians, pediatricians and infectious disease specialists. We collected 
data on the provision of injection services in or in proximity of physician offices, 
and obtained data from physicians’ prescriptions in the previous three-month 
period. We analyzed the data using ANOVA, Student’s t-test and linear regres-
sion methods. Results: We obtained complete data from 465 of 600 sampled 
physicians. Overall 41.9% of prescriptions contained injectable medicines. 75% of 
physicians offered injection services in their offices. Male physicians and general 
physicians were more likely to offer the services, and more likely to prescribe 
injectables. We observed a clear linear relationship between the injection ser-
vice working hours and the proportion of prescriptions containing injectables 
(p-value< 0.001). cOnclusiOns: Providing injection service in the office was 
directly linked with the proportion of prescriptions containing injectables. While 
provision of injection services may provide a direct financial benefit to physicians, 
